The IVD Drug Test Electrolyte Cluster: Carbon dioxide, Calcium, Magnesium, Phosphate, Chloride.
Vietnam·Risk Class TTBYT Loại B·Theo theo phụ lục·Theo theo phụ lục·Registered Aug 31, 2023- Analysis ID
- 230002157/PCBB-HN
- Submission ID
- 000.00.19.H26-230828-0016
- Product Type
- Theo theo phụ lục
- Product Code
- Theo phụ lục
- Manufacturer
- Theo theo phụ lục
- Manufacturer Country
- Theo theo phụ lục
- Intended Use
- CO2: Used in in vitro diagnosis to determine the concentration of carbon dioxide in human serum or plasma. Ca-CPC: Used in in vitro diagnosis to determine the concentration of calcium in human serum, plasma, or urine Ca-ARS: Used in in vitro diagnosis to determine the concentration of calcium in human serum, plasma, or urine CL: Used in in vitro diagnosis to determine the concentration of chloride in human serum, plasma. Mg-XB: Used in in vitro diagnosis to determine the concentration of magnesium in human serum or plasma. Phos: Used in in vitro diagnosis to determine the concentration of inorganic phosphate in human serum, plasma, or urine.
- Registration Date
- Aug 31, 2023
Companies providing products similar to "The IVD Drug Test Electrolyte Cluster: Carbon dioxide, Calcium, Magnesium, Phosphate, Chloride."
Recently registered similar products
Access comprehensive regulatory information for The IVD Drug Test Electrolyte Cluster: Carbon dioxide, Calcium, Magnesium, Phosphate, Chloride. in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230002157/PCBB-HN and manufactured by Theo theo phụ lục.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo theo phụ lục, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.